Publication | Closed Access

Selective dopamine D3 receptor antagonists enhance cortical acetylcholine levels measured with high-performance liquid chromatography/tandem mass spectrometry without anti-cholinesterases

MedicineNeurotransmitterNeuropeptide ReceptorNeuropharmacologyCortical Acetylcholine LevelsNeuroscienceCentral Nervous SystemDopaminePharmacologyNeurochemistryNeuropeptides